nicotinamide mononucleotide has been researched along with Impaired Glucose Tolerance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asalla, S; Desai, T; Ghadieh, HE; Ghanem, SS; Giacca, A; Ivovic, A; Jentz, EM; Joseph, JW; Joseph, YD; Mori, Y; Muturi, HT; Nahle, A; Najjar, SM; Pereira, S; Poon, F | 1 |
| Dasgupta, B; Garten, A; Imai, S; Kiess, W; Körner, A; Milbrandt, J; Mills, KF; Revollo, JR; Sasaki, Y; Satoh, A; Townsend, RR; Wang, T; Wolberger, C | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Nicotinamide Mononucleotide Prevents Free Fatty Acid-Induced Reduction in Glucose Tolerance by Decreasing Insulin Clearance.
Topics: Animals; Fatty Acids, Nonesterified; Glucose; Glucose Intolerance; Hep G2 Cells; Humans; Infusions, Intravenous; Insulin; Male; Mice; Mice, Inbred C57BL; NAD; Nicotinamide Mononucleotide; Oleic Acid; Sirtuin 1; Up-Regulation | 2021 |
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.
Topics: Adipose Tissue, Brown; Animals; Cell Differentiation; Cell Line; Female; Glucose Intolerance; Immunoprecipitation; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Signal Transduction | 2007 |